Bristol-Myers Squibb’s multiple sclerosis therapy ozanimod has been approved by the FDA right on schedule, but the company has put the launch on ice while it waits for the coronavirus pandemic ...

Viatris has made a play to expand its branded medicines business by licensing two late-stage drugs from Idorsia – for acute myocardial infarction (AMI) and systemic lupus erythematosus (SLE ...

本文综述 2023 - 2024 年德国上市的多靶点药物（MTDLs），探讨多药药理学的应用与前景。 多药药理学：药物研发的创新范式 多药药理学作为药物发现和治疗发展中的创新理念，与传统 “一对一” 的药物研发模式不同，它致力于开发能同时调节生物系统中多个分子 ...

Figure 1. Cyclic Rho GTPase modulation, functions, and TRP channel-mediated regulation hypothesis. Rho GTPases cycle between an active form bound to GTP (blue arrows) and an inactive form that is ...

College of Traditional Chinese Medicine, Capital Medical University, Beijing, China Objective: Rhodiola is a common Chinese herb in the treatment of cerebral small vessel disease (cSVD). Umbelliferone ...

Cardiovascular disease is the leading cause of mortality in patients with chronic kidney disease (CKD). APOM plays a critical role in reverse cholesterol transport by facilitating the formation of pre ...